New hope for ovarian cancer: could Rina-S outperform standard chemo?
Disease control
Not yet recruiting
This study tests a new drug called Rina-S (with or without bevacizumab) against standard platinum-based chemotherapy for people with ovarian cancer that has come back but still responds to platinum treatments. About 688 participants will be randomly assigned to receive either the…
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated May 11, 2026 20:46 UTC